Aaron Ondrey

Financieel Directeur/CFO bij ROCKET PHARMACEUTICALS, INC.

Vermogen: 997 371 $ op 31-05-2024

48 jaar

Health Technology

Consumer Services

Actieve functies van Aaron Ondrey

Bedrijven	Functie	Begin	Einde
ROCKET PHARMACEUTICALS, INC.	Financieel Directeur/CFO	26-03-2024	-

Bedrijven	Functie	Begin	Einde
MIRATI THERAPEUTICS	Financieel Directeur/CFO	08-09-2023	23-01-2024
MIRATI THERAPEUTICS	Corporate Officer/Principal	01-07-2022	08-09-2023
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	01-03-2010	01-11-2018

Case Western Reserve University

Undergraduate Degree

Internationaal

Verenigde Staten

Operationeel

Director of Finance/CFO	2
Corporate Officer/Principal	2
Undergraduate Degree	1

Sectoraal

Health Technology	4
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
ROCKET PHARMACEUTICALS, INC.	Health Technology
REGENERON PHARMACEUTICALS, INC.	Health Technology

Bedrijven in privébezit	1
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.	Health Technology

Bedrijven in privébezit

Health Technology